No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antineoplastic Agents, Immunological* / adverse effects
-
Brentuximab Vedotin
-
Hodgkin Disease* / drug therapy
-
Humans
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Brentuximab Vedotin
-
pembrolizumab